(Q51155798)

English

Dose intensity as a therapeutic strategy in breast cancer

scientific article published on December 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/1687202

Dose intensity as a therapeutic strategy in breast cancer (English)

1 reference

10.1007/BF01908239

https://api.crossref.org/works/10.1007/BF01908239

29 October 2022

1 reference

10.1007/BF01908239

https://api.crossref.org/works/10.1007/BF01908239

29 October 2022

author name string

C. K. Osborne

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687202

29 October 2022

language of work or name

0 references

publication date

1 December 1991

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/1687202

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF01908239.pdf

Portable Document Format

1 reference

10.1007/BF01908239

https://api.crossref.org/works/10.1007/BF01908239

29 October 2022

http://link.springer.com/article/10.1007/BF01908239/fulltext.html

1 reference

10.1007/BF01908239

https://api.crossref.org/works/10.1007/BF01908239

29 October 2022

http://link.springer.com/content/pdf/10.1007/BF01908239

1 reference

10.1007/BF01908239

https://api.crossref.org/works/10.1007/BF01908239

29 October 2022

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/1687202

20 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/1687202

S11-4

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/1687202

https://scigraph.springernature.com/pub.10.1007/bf01908239

0 references

Dose-response in the treatment of breast cancer: a critical review

1 reference

https://pubmed.ncbi.nlm.nih.gov/1687202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1687202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Average relative dose intensity and the impact on design of clinical trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1687202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1687202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1687202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose induction chemotherapy of metastatic breast cancer in protected environment: a prospective randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1687202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01908239

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/1687202

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/1687202

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51155798&oldid=1760444064"